The National Institute on Drug Abuse (NIDA) is issuing a Small Business Sources Sought notice to collect capability statements from qualified small businesses that can serve as a data, statistics, and clinical‑trial support center for its Clinical Trials Network. Respondents must demonstrate experience in managing data systems, statistical analysis, document management, and overall clinical‑trial operations for roughly 20 concurrent substance‑use‑disorder trials. The effort includes establishing secure web‑based data capture platforms, designing statistical analysis plans, monitoring data quality, tracking trial performance, coordinating DSMB meetings, and providing expert consultation. Vendors must detail relevant work experience, organizational capacity, qualified personnel (PhDs and Masters‑level staff), and facility/IT infrastructure. No contract is guaranteed; the notice is purely for market research to inform future acquisition strategy.
• Target audience: Small businesses (including 8(a), HUBZone, veteran‑owned, women‑owned, etc.) with ≤1,000 employees.
• Scope: Provide end‑to‑end data management and statistical services for multi‑site SUD clinical trials.
• Key deliverables: Secure data capture systems, statistical design/analysis, quality‑control monitoring, performance dashboards, DSMB coordination, and expert consulting.
• Submission: Capability statement electronically by 1:00 PM EST, 30 Sept 2026; subject line must include title and solicitation number.
• Evaluation criteria: Work experience, organizational experience, personnel qualifications, facilities/IT capabilities, and any partnership information.